Hims & Hers Health, Inc. (HIMS) is a Medical - Equipment & Services company in the Healthcare sector, currently trading at $21.36. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HIMS = $97.20 (+355.1% from the current price, the stock appears undervalued). Analyst consensus target is HIMS = $30 (+40.1% upside).
Valuation: HIMS trades at a trailing Price-to-Earnings (P/E) of 33.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.26.
Financials: revenue is $2.3B, +64.6%/yr average growth. Net income is $128M, growing at +233.8%/yr. Net profit margin is 5.5% (thin). Gross margin is 73.8% (-3.8 pp trend).
Balance sheet: total debt is $1.3B against $541M equity (Debt-to-Equity (D/E) ratio 2.34, leveraged). Current ratio is 1.9 (strong liquidity). Debt-to-assets is 58.7%. Total assets: $2.2B.
Analyst outlook: 6 / 19 analysts rate HIMS as buy (32%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 73/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 67/100 (Partial), Moat 65/100 (Partial), Future 52/100 (Partial), Income 45/100 (Partial).
